Predicting Symptom Onset of Genetic Prion Diseases Using Fluid Biomarkers.
作者信息
Appleby Brian S
机构信息
From the Departments of Neurology, Pathology, and Psychiatry, Case Western Reserve University School of Medicine, Cleveland, OH.
出版信息
Neurology. 2024 Jul 23;103(2):e209580. doi: 10.1212/WNL.0000000000209580. Epub 2024 Jun 19.
Abstract
摘要
相似文献
1
Predicting Symptom Onset of Genetic Prion Diseases Using Fluid Biomarkers.使用液体生物标志物预测遗传性朊病毒病的症状发作
Neurology. 2024 Jul 23;103(2):e209580. doi: 10.1212/WNL.0000000000209580. Epub 2024 Jun 19.
2
Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.遗传性朊病毒病的脑脊液生物标志物的诊断准确性。
Brain. 2022 Apr 18;145(2):700-712. doi: 10.1093/brain/awab350.
3
Presymptomatic and preimplantation genetic diagnosis: neurology, NextGenetics, and the next generation.症状前和植入前基因诊断：神经学、下一代遗传学与下一代
JAMA Neurol. 2014 Apr;71(4):403-4. doi: 10.1001/jamaneurol.2013.5834.
4
Human prion diseases.人类朊病毒疾病
Baillieres Clin Neurol. 1994 Aug;3(2):241-7.
5
Gerstmann-Straussler-Scheinker disease due to a novel prion protein gene mutation.由新型朊蛋白基因突变引起的格斯特曼-施特劳斯勒-谢inker病
Neurology. 2011 Feb 1;76(5):485-7. doi: 10.1212/WNL.0b013e31820a0ab2.
6
Multiple prion types in the same brain: is a molecular diagnosis of CJD possible?同一大脑中存在多种朊病毒类型：克雅氏病的分子诊断是否可行？
Neurology. 1999 Dec 10;53(9):1903-4. doi: 10.1212/wnl.53.9.1903.
7
Towards a treatment for genetic prion disease: trials and biomarkers.针对遗传性朊病毒病的治疗方法：临床试验与生物标志物。
Lancet Neurol. 2020 Apr;19(4):361-368. doi: 10.1016/S1474-4422(19)30403-X. Epub 2020 Mar 18.
8
Prion disease.朊病毒病
Neurol Clin. 2007 Aug;25(3):833-42, viii. doi: 10.1016/j.ncl.2007.03.006.
9
Prions: protein aggregation and infectious diseases.朊病毒：蛋白质聚集与传染病
Physiol Rev. 2009 Oct;89(4):1105-52. doi: 10.1152/physrev.00006.2009.
10
Early and persistent sensory-psychiatric symptoms in an inherited prion disease with a PrP P105L mutation.一种具有PrP P105L突变的遗传性朊病毒病的早期持续性感觉-精神症状。
J Neurol. 2002 Dec;249(12):1740-1. doi: 10.1007/s00415-002-0907-x.
本文引用的文献
1
Fluid Biomarkers in Individuals at Risk for Genetic Prion Disease up to Disease Conversion.遗传朊病毒病风险个体在疾病转化前的体液生物标志物。
Neurology. 2024 Jul 23;103(2):e209506. doi: 10.1212/WNL.0000000000209506. Epub 2024 Jun 19.
2
Detection of Prion Protein Seeding Activity in Tear Fluids.泪液中朊病毒蛋白种子活性的检测
N Engl J Med. 2023 May 11;388(19):1816-1817. doi: 10.1056/NEJMc2214647.
3
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease.朊病毒病风险个体的种子扩增和神经退行性标记物轨迹。
Brain. 2023 Jun 1;146(6):2570-2583. doi: 10.1093/brain/awad101.
4
Genetic aspects of human prion diseases.人类朊病毒疾病的遗传学方面。
Front Neurol. 2022 Oct 5;13:1003056. doi: 10.3389/fneur.2022.1003056. eCollection 2022.
5
Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases.遗传性朊病毒病的脑脊液生物标志物的诊断准确性。
Brain. 2022 Apr 18;145(2):700-712. doi: 10.1093/brain/awab350.
6
Towards a treatment for genetic prion disease: trials and biomarkers.针对遗传性朊病毒病的治疗方法：临床试验与生物标志物。
Lancet Neurol. 2020 Apr;19(4):361-368. doi: 10.1016/S1474-4422(19)30403-X. Epub 2020 Mar 18.
7
Age at onset in genetic prion disease and the design of preventive clinical trials.遗传性朊病毒病的发病年龄与预防性临床试验设计。
Neurology. 2019 Jul 9;93(2):e125-e134. doi: 10.1212/WNL.0000000000007745. Epub 2019 Jun 6.
8
Clinical trials.临床试验。
Handb Clin Neurol. 2018;153:431-444. doi: 10.1016/B978-0-444-63945-5.00024-6.
9
Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies.致死性家族性失眠症的症状前诊断：系列神经生理学和18氟脱氧葡萄糖正电子发射断层显像研究
Brain. 2006 Mar;129(Pt 3):668-75. doi: 10.1093/brain/awl003. Epub 2006 Jan 6.
Zotero 插件